These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11932265)

  • 1. Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?
    Wang C; Swerdloff RS
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1462-6. PubMed ID: 11932265
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of transdermal dihydrotestosterone in the aging male: a prospective, randomized, double blind study.
    Kunelius P; Lukkarinen O; Hannuksela ML; Itkonen O; Tapanainen JS
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1467-72. PubMed ID: 11932266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement therapy in the climacteric: benefits beyond sexuality.
    Maia H; Casoy J; Valente J
    Gynecol Endocrinol; 2009 Jan; 25(1):12-20. PubMed ID: 19165658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen effect on body composition and fat metabolism.
    Jensen MD
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S65-8; discussion S68-9. PubMed ID: 10959220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of erectile disorders with androgens: When? How?].
    Tostain J; Legon C; Ludot T; Castro R; Li GR
    Prog Urol; 1997 Apr; 7(2):314-9. PubMed ID: 9264778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andropause and testosterone supplementation for cognitive loss.
    Tan RS
    J Androl; 2002; 23(1):45-6. PubMed ID: 11780921
    [No Abstract]   [Full Text] [Related]  

  • 7. Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty.
    Keenan BS; Richards GE; Ponder SW; Dallas JS; Nagamani M; Smith ER
    J Clin Endocrinol Metab; 1993 Apr; 76(4):996-1001. PubMed ID: 8473416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrative review on current evidence of testosterone replacement therapy for the andropause.
    Tan RS; Culberson JW
    Maturitas; 2003 May; 45(1):15-27. PubMed ID: 12753940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone substitution--a questionable IGeL indication].
    Hakimi R
    MMW Fortschr Med; 2006 Jul; 148(27-28):16. PubMed ID: 16888853
    [No Abstract]   [Full Text] [Related]  

  • 10. Andropause (androgen deficiency of the aging male): diagnosis and management.
    Staerman F; Léon P
    Minerva Med; 2012 Oct; 103(5):333-42. PubMed ID: 23042368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD; Dallas JS; Ponder SW; Keenan BS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Masculine vitality: pros and cons of testosterone in treating the andropause.
    Asthana S; Bhasin S; Butler RN; Fillit H; Finkelstein J; Harman SM; Holstein L; Korenman SG; Matsumoto AM; Morley JE; Tsitouras P; Urban R
    J Gerontol A Biol Sci Med Sci; 2004 May; 59(5):461-5. PubMed ID: 15123756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Andropause and its treatment].
    Regno FD
    Clin Ter; 1975 Nov; 75(3):219-26. PubMed ID: 1227764
    [No Abstract]   [Full Text] [Related]  

  • 14. [An update on the pharmacological therapy of the andropause].
    Fanghänel G; Yamamoto J; Sánchez-Reyes L; Zárate A
    Gac Med Mex; 2000; 136(2):175-81. PubMed ID: 10815331
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum androgen bioactivity during 5alpha-dihydrotestosterone treatment in elderly men.
    Raivio T; Tapanainen JS; Kunelius P; Jänne OA
    J Androl; 2002; 23(6):919-21. PubMed ID: 12399539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen supplementation in elderly males: is dihydrotestosterone to be preferred?
    Vermeulen A
    Aging Male; 2004 Dec; 7(4):325-7. PubMed ID: 15799129
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency.
    Meier C; Liu PY; Ly LP; de Winter-Modzelewski J; Jimenez M; Handelsman DJ; Seibel MJ
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3033-41. PubMed ID: 15181095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andropause: an old concept in new clothing.
    Morley JE; Perry HM
    Clin Geriatr Med; 2003 Aug; 19(3):507-28. PubMed ID: 14567004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andropause: coming of age for an old concept?
    Heaton JP
    Curr Opin Urol; 2001 Nov; 11(6):597-601. PubMed ID: 11734696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety aspects of androgen treatment with 5alpha-dihydrotestosterone.
    Sakhri S; Gooren LJ
    Andrologia; 2007 Dec; 39(6):216-22. PubMed ID: 18076420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.